• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Potential role for interferon gamma in the treatment of recurrent ventilator-acquired pneumonia in patients with COVID-19: a hypothesis.

作者信息

Nguyen Lee S, Ait Hamou Zakaria, Gastli Nabil, Chapuis Nicolas, Pène Frédéric

机构信息

Service de Médecine Intensive-Réanimation, Hôpital Cochin, AP-HP. Centre, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France.

Research and Innovation Department, CMC Ambroise Paré, RICAP, Neuilly-sur-Seine, France.

出版信息

Intensive Care Med. 2021 May;47(5):619-621. doi: 10.1007/s00134-021-06377-3. Epub 2021 Mar 10.

DOI:10.1007/s00134-021-06377-3
PMID:33688993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7943696/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e92/7943696/74d5310332ec/134_2021_6377_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e92/7943696/74d5310332ec/134_2021_6377_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e92/7943696/74d5310332ec/134_2021_6377_Fig1_HTML.jpg

相似文献

1
Potential role for interferon gamma in the treatment of recurrent ventilator-acquired pneumonia in patients with COVID-19: a hypothesis.γ-干扰素在治疗新型冠状病毒肺炎患者复发性呼吸机相关性肺炎中的潜在作用：一项假说
Intensive Care Med. 2021 May;47(5):619-621. doi: 10.1007/s00134-021-06377-3. Epub 2021 Mar 10.
2
Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia and Ventilator-Associated Tracheobronchitis in COVID-19.新型冠状病毒肺炎（COVID-19）中的医院获得性肺炎/呼吸机相关性肺炎及呼吸机相关性气管支气管炎
Semin Respir Crit Care Med. 2022 Apr;43(2):243-247. doi: 10.1055/s-0041-1740334. Epub 2022 Jan 18.
3
Impact of the modification of a cleaning and disinfection method of mechanical ventilators of COVID-19 patients and ventilator-associated pneumonia: One year of experience.COVID-19 患者机械通气设备清洗消毒方法改良对呼吸机相关性肺炎的影响：一年经验。
Am J Infect Control. 2021 Dec;49(12):1474-1480. doi: 10.1016/j.ajic.2021.09.012. Epub 2021 Sep 20.
4
Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study.新型冠状病毒感染与呼吸机相关性下呼吸道感染发病率的关系：一项欧洲多中心队列研究。
Intensive Care Med. 2021 Feb;47(2):188-198. doi: 10.1007/s00134-020-06323-9. Epub 2021 Jan 3.
5
Risk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational study.严重 COVID-19 患者发生呼吸机相关性下呼吸道感染的危险因素：一项多中心、前瞻性观察性研究。
Sci Rep. 2023 Apr 21;13(1):6553. doi: 10.1038/s41598-023-32265-5.
6
The Brief Case: Ventilator-Associated Corynebacterium accolens Pneumonia in a Patient with Respiratory Failure Due to COVID-19.病例摘要：一名因 COVID-19 导致呼吸衰竭的患者发生呼吸机相关性阿氏棒状杆菌肺炎
J Clin Microbiol. 2021 Aug 18;59(9):e0013721. doi: 10.1128/JCM.00137-21.
7
Closing the Brief Case: Ventilator-Associated Corynebacterium accolens Pneumonia in a Patient with Respiratory Failure Due to COVID-19.病例总结：1例因新型冠状病毒肺炎（COVID-19）导致呼吸衰竭患者发生呼吸机相关性阿氏棒状杆菌肺炎
J Clin Microbiol. 2021 Aug 18;59(9):e0013821. doi: 10.1128/JCM.00138-21.
8
Incidence, Characteristics, and Outcomes of Ventilator-associated Events during the COVID-19 Pandemic.COVID-19 大流行期间呼吸机相关性事件的发生率、特征和结局。
Ann Am Thorac Soc. 2022 Jan;19(1):82-89. doi: 10.1513/AnnalsATS.202103-364OC.
9
[Imipenem-cilastatin-relebactam used to treat ventilator-associated pneumonia developing after infection with SARS-CoV-2].[亚胺培南-西司他丁-瑞来巴坦用于治疗新型冠状病毒感染后发生的呼吸机相关性肺炎]
Klin Mikrobiol Infekc Lek. 2022 Mar;28(1):18-21.
10
Selective digestive decontamination to reduce the high rate of ventilator-associated pneumonia in critical COVID-19.采用选择性消化道去污以降低重症新型冠状病毒肺炎患者呼吸机相关性肺炎的高发生率。
Anaesth Crit Care Pain Med. 2022 Feb;41(1):100987. doi: 10.1016/j.accpm.2021.100987. Epub 2021 Nov 26.

引用本文的文献

1
Transcriptomic signatures of neonatal acute respiratory distress syndrome in a prospective cohort of respiratory distress.前瞻性呼吸窘迫队列中新生儿急性呼吸窘迫综合征的转录组特征
iScience. 2025 Jun 25;28(8):113007. doi: 10.1016/j.isci.2025.113007. eCollection 2025 Aug 15.
2
A Modular Mathematical Model of the Immune Response for Investigating the Pathogenesis of Infectious Diseases.一种用于研究传染病发病机制的免疫反应模块化数学模型。
Viruses. 2025 Apr 22;17(5):589. doi: 10.3390/v17050589.
3
Integrating genetic and immune factors to uncover pathogenetic mechanisms of viral-associated pulmonary aspergillosis.

本文引用的文献

1
Increased susceptibility to intensive care unit-acquired pneumonia in severe COVID-19 patients: a multicentre retrospective cohort study.重症新型冠状病毒肺炎患者发生重症监护病房获得性肺炎的易感性增加：一项多中心回顾性队列研究
Ann Intensive Care. 2021 Jan 29;11(1):20. doi: 10.1186/s13613-021-00812-w.
2
Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study.新型冠状病毒感染与呼吸机相关性下呼吸道感染发病率的关系：一项欧洲多中心队列研究。
Intensive Care Med. 2021 Feb;47(2):188-198. doi: 10.1007/s00134-020-06323-9. Epub 2021 Jan 3.
3
整合遗传和免疫因素以揭示病毒相关性肺曲霉病的发病机制。
mBio. 2024 Jun 12;15(6):e0198223. doi: 10.1128/mbio.01982-23. Epub 2024 Apr 23.
4
ICU-acquired infections in immunocompromised patients.免疫功能低下患者 ICU 获得性感染。
Intensive Care Med. 2024 Mar;50(3):332-349. doi: 10.1007/s00134-023-07295-2. Epub 2024 Jan 10.
5
Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2.细菌诱导或被动给予的干扰素 γ 可使肺部适应早期控制 SARS-CoV-2。
Nat Commun. 2023 Dec 12;14(1):8229. doi: 10.1038/s41467-023-43447-0.
6
Unlocking therapeutic potential: integration of drug repurposing and immunotherapy for various disease targeting.释放治疗潜力：药物重新利用与免疫疗法针对多种疾病靶点的整合。
Am J Transl Res. 2023 Aug 15;15(8):4984-5006. eCollection 2023.
7
Case Report: Intercurrent infections in COVID-19-induced sustained immunodepression: is interferon gamma a suitable drug?病例报告：COVID-19 引起的持续性免疫抑制中的并发感染：干扰素 γ 是一种合适的药物吗？
Front Immunol. 2023 Jun 8;14:1183665. doi: 10.3389/fimmu.2023.1183665. eCollection 2023.
8
Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial.γ-1b 干扰素预防危重症患者医院获得性肺炎的疗效：一项 2 期、安慰剂对照随机临床试验。
Intensive Care Med. 2023 May;49(5):530-544. doi: 10.1007/s00134-023-07065-0. Epub 2023 Apr 18.
9
Monocytic HLA-DR Expression in Immune Responses of Acute Pancreatitis and COVID-19.单核细胞 HLA-DR 表达在急性胰腺炎和 COVID-19 的免疫反应中的作用。
Int J Mol Sci. 2023 Feb 7;24(4):3246. doi: 10.3390/ijms24043246.
10
Prevention and treatment of ventilator-associated pneumonia in COVID-19.新型冠状病毒肺炎中呼吸机相关性肺炎的防治
Front Pharmacol. 2022 Oct 19;13:945892. doi: 10.3389/fphar.2022.945892. eCollection 2022.
Monocyte HLA-DR Measurement by Flow Cytometry in COVID-19 Patients: An Interim Review.
流式细胞术检测 COVID-19 患者单核细胞 HLA-DR：一项中期综述。
Cytometry A. 2020 Dec;97(12):1217-1221. doi: 10.1002/cyto.a.24249. Epub 2020 Nov 4.
4
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.COVID-19 患者严重呼吸衰竭的复杂免疫失调。
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3. doi: 10.1016/j.chom.2020.04.009. Epub 2020 Apr 21.
5
Multicentric experience with interferon gamma therapy in sepsis induced immunosuppression. A case series.脓毒症诱导免疫抑制的干扰素 γ 治疗的多中心经验。病例系列。
BMC Infect Dis. 2019 Nov 5;19(1):931. doi: 10.1186/s12879-019-4526-x.
6
Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study.免疫功能障碍的细胞表面特征对危重症患者进行风险分层：INFECT 研究。
Intensive Care Med. 2018 May;44(5):627-635. doi: 10.1007/s00134-018-5247-0. Epub 2018 Jun 7.